MedPath

A multicentre, randomised, double-blind, double dummy, parallel group study to compare the salmeterol/fluticasone propionate combination SERETIDE at a dose of 50/100mcg twice daily and fluticasone propionate FLIXOTIDE at a dose of 200mcg twice daily, both delivered via a dry powder inhaler DISKUS for 12 weeks in asthma in children aged 4-11 years not controlled by inhaled corticosteroids alone at medium dose

Conditions
Asthma in children aged 4-11 years not controlled by inhaled corticosteroids alone at medium dose.
MedDRA version: 6.1Level: PTClassification code 10003553
Registration Number
EUCTR2005-002949-40-IT
Lead Sponsor
GLAXO SMITHKLINE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
506
Inclusion Criteria

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath